期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

药物诱导的自身免疫性肝炎3例报告 被引量：1

Three cases of drug-induced autoimmune hepatitis
下载PDF
导出
摘要 由药物触发的自身免疫反应引起的肝细胞损伤，称之为药物诱发的自身免疫性肝炎（drug-induced autoimmune hepatitis， DAIH）。近几年来药物性肝损害的患者越来越多，由药物性肝损害发展为DAIH的患者也逐年增加，然而由于其发病率低，临床特征不典型，容易被忽视，且易与普通药物性肝损害混淆。本文报道3例药物诱发的自身免疫性肝炎。
作者 炉军
机构地区 南昌市第九医院重症监护科
出处 《临床肝胆病杂志》 CAS 2014年第5期449-450,共2页 Journal of Clinical Hepatology
关键词 肝炎 自身免疫性 药物性肝损伤 病例报告 hepatitis, autoimmune drug - induced liver injury case reports
分类号 R575.1 [医药卫生—消化系统]
  • 相关文献

参考文献14

  • 1SUZUKI A, BRUNT EM, KLEINER DE, et al. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver iniury [ J ]. Hepatology, 2011, 54(3):931 -939.
  • 2FONTANA R J, SEEFF LB, ANDRADE R J, et al. Standardiza- tion of nomenclature and causality assessment in drug-in- duced liver injury: summary of a clinical research workshop [J]. Hepatology, 2010, 52(2): 730 -742.
  • 3LUTH S, WEILER -NORMANN C, SCHRAMM C, et al. Au- toimmune liver diseases [ J ]. Internist( Berl), 2009, 50 ( 3 ) : 310 -317.
  • 4禹铮,贾继东.药物性肝损害的危险因素、诊断规范及停药标准[J].临床肝胆病杂志,2013,29(9):674-677. 被引量：18
  • 5MANNS MP, CZAJA A J, GORHAM JD, et al. Diagnosis and management of autoimmune hepatitis [ J ]. Hepatology, 2010, 51 (6): 2193 -2213.
  • 6LEWIS JH. Diagnosis: liver biopsy differentiates DILl from autoimmune hepatitis [ J ]. Nat Rev Gastroenterol Hepatol, 2011, 8(10): 540 -542.
  • 7WEILER-NORMANN C, SCBRAMIN C. Drug induced liver injury and its relationship to autoinmmne hepatitis [ J ]. J Hepatol, 2011, 55(4): 747-749.
  • 8JAMES ROCHON, PETR PROTIVA, LEONARD B, et al. Re- liability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug -induced liver injury[J]. Hep- atology, 2008, 48(4): 1175 -1183.
  • 9高敏照,刘玉兰.187例自身免疫性肝病的临床特点分析[J].临床肝胆病杂志,2011,27(10):1066-1068. 被引量：14
  • 10刘燕敏.药物性肝损害伴自身抗体阳性患者临床特征及转归[J].临床肝胆病杂志,2012,28(5):335-338. 被引量：10

二级参考文献45

  • 1Roger Klein Moreira,Frank Revetta,Elizabeth Koehler,Mary Kay Washington.Diagnostic utility of IgG and IgM immunohistochemistry in autoimmune liver disease[J].World Journal of Gastroenterology,2010,16(4):453-457. 被引量：11
  • 2Manns MP, Czaja A J, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis [ J ]. Hepatology, 2010, 51 (6):2193 -2213.
  • 3Lindor KD, Gershwin ME, Poupon R, et al. Primary biliary cirrhosis[ J ]. Hepatology, 2009, 50 ( 1 ):291 -308.
  • 4Ghonaim M, AI - Ghamdi A, El - Bana H, et al. Autoantibodies in chronic liver disease[J]. Egypt J Immunol, 2005, 12 (2): 101 -111.
  • 5Invernizzi P, Selmi C, Ranftler C, et al. Antinuclear antibodies in primary biliary cirrhosis[J]. Semin Liver Dis, 2005, 25 (3): 298 -310.
  • 6Ishibashi H, Komori A, Shimoda S, et al. Guidelines for therapy of autoimmune liver disease[J]. Semin Liver Dis, 2007, 27(2) : 214 -226.
  • 7Janowitz P, Kratzer W, Wechsler J G. Positive effect of ursodeoxycholic acid on liver enzymes in autoimmune hepatitis with little activity - a pilot study [ J ]. Leber Magen Darm, 1996, 26(6) :310 -313.
  • 8Miyake Y, Iwasaki Y, Kobashi H, et al. Efficacy of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis[J]. Hepatollnt, 2009,3(4), 556 -562.
  • 9Czaja A J, Carpenter HA, Lindor KD. Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo - controlled treatment trial [ J ]. Hepatology,1999, 30 (6) : 1381 -1386.
  • 10Chalasani N, Fontana R J. Bonkovsky HL, et al. Causes, clinical features, and outcomes from a prospective study of drug -induced liver injury in the united states[ J ]. Gastroenterology, 2008,135(6) :1924 -1934.

共引文献43

同被引文献5

引证文献1

二级引证文献1

临床肝胆病杂志
2014年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部